Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Authors: Giorgio V. Scagliotti, Rabab Gaafar, Anna K. Nowak, Takashi Nakano, Jan P. van Meerbeeck, Sanjay Popat, Nicholas J. Vogelzang, Federica Grosso, Rasha Aboelhassan, Marko Jakopović, Giovanni Luca Ceresoli, Paul Taylor, Francesco Orlandi, Dean A. Fennell, Silvia Novello, Arnaud Scherpereel, Kozo Kuribayashi, S. Cedrés, Jens Benn Sørensen, Nick Pavlakis, Martin Reck, Derek Velema, Ute von Wangenheim, Miyoung Kim, José Barrueco, Anne S. Tsao - The Lancet 2019 cited by 167